|
Volumn 381, Issue 9873, 2013, Pages 1183-
|
Authors' reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
C REACTIVE PROTEIN;
EZETIMIBE;
LOMITAPIDE;
BENZIMIDAZOLE DERIVATIVE;
CARRIER PROTEIN;
CLINICAL PRACTICE;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG SAFETY;
FATTY LIVER;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERCHOLESTEROLEMIA;
INFLAMMATION;
INSULIN RESISTANCE;
LETTER;
LIPID STORAGE;
LIVER BIOPSY;
LIVER FIBROSIS;
PRIORITY JOURNAL;
SIDE EFFECT;
STEATOSIS;
TREATMENT DURATION;
DRUG ANTAGONISM;
FAMILIAL HYPERCHOLESTEROLEMIA;
FEMALE;
MALE;
NOTE;
BENZIMIDAZOLES;
CARRIER PROTEINS;
FEMALE;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
MALE;
|
EID: 84876325159
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/s0140-6736(13)60798-9 Document Type: Letter |
Times cited : (5)
|
References (5)
|